Russell Investments Group’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7K Buy
4,320
+246
+6% +$1.08K ﹤0.01% 3819
2026
Q1
$15.6K Buy
4,074
+2,606
+178% +$10.7K ﹤0.01% 3683
2025
Q4
$5.45K Sell
1,468
-10,923
-88% -$93.7K ﹤0.01% 3899
2025
Q3
$175K Buy
+12,391
New +$193K ﹤0.01% 2857
2024
Q4
Sell
-633
Closed -$6.43K 3765
2024
Q3
$6.43K Sell
633
-2,463
-80% -$73.3K ﹤0.01% 3172
2024
Q2
$179K Hold
3,096
﹤0.01% 2505
2024
Q1
$103K Sell
3,096
-160
-5% -$8.1K ﹤0.01% 2573
2023
Q4
$264K Buy
+3,256
New +$265K ﹤0.01% 2375
2023
Q3
Sell
-18
Closed -$5.93K 3594
2023
Q2
$5.93K Buy
18
+1
+6% +$305 ﹤0.01% 3069
2023
Q1
$4.75K Buy
+17
New +$6.24K ﹤0.01% 2948

Other funds holding OM

Russell Investments Group's OM Position: Q2 2026 in Review

Russell Investments Group increased its Outset Medical (OM) stake by 6% in Q2 2026, buying an estimated $1.08K and bringing the position to 4,320 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3819.

Russell Investments Group first reported a position in OM in Q1 2023 and has held it in 10 quarters since. The position peaked at $264K in Q4 2023. 34 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Russell Investments Group held 4,320 shares of Outset Medical worth $18.7K as of Q2 2026.
  • Russell Investments Group bought 246 Outset Medical shares in Q2 2026, an estimated $1.08K.
  • Outset Medical made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3819 holding.
  • Russell Investments Group first reported a position in Outset Medical in Q1 2023 and has held it in 10 quarters since.
  • Russell Investments Group's Outset Medical position peaked at $264K in Q4 2023.
  • 34 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.